RNAC Competitors & Alternatives
Compare Cartesian Therapeutics Inc. with similar stocks in the same industry
Biotechnology
RNAC
Main Stock$6.21
Tradestie Score
49
Market Cap
$266.26M
Revenue Growth
-0.9%
Analyst Upside
+442.1%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.67
|
$240.89M | - | 31 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.59
|
$231.77M | - | 49 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.65
|
$227.00M | - | 45 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.34
|
$211.22M | - | 46 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.70
|
$202.58M | - | 64 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$6.91
|
$170.45M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.46
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.28
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.22
|
$133.50M | - | 63 | Compare |
More RNAC Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry